Modal Title

Modal Description

Bird & Bird advised Biomemory on its €17 million fundraising round

Published

Dec 23 2024

Related

Practices

Sectors

Countries

International law firm Bird & Bird advised Biomemory, a French deeptech pioneer in DNA data storage, on its €17 million Series A funding round, with new investors Crédit Mutuel Innovation, Blast.club, Bpifrance, Sorbonne Venture and Adnexus, and its existing shareholders.

Founded in 2021, this innovative deeptech spin-off from CNRS/Sorbonne University’s first objective is to produce DNA printers that can transform binary information into AGTC information (the four types of DNA nucleotide).

Two years after a €5 million seed round, Biomemory plans to use this new funding to expand its team by recruiting promising talent in molecular biology and engineering to accelerate product development and commercialisation. 

The Bird & Bird team advising on the deal consisted of lead partner Félicien Bardsley and associate Céline Sol. 

News & Deals

More News & Deals
Deal Bird & Bird advises Proteome Sciences plc on placing, subscription and oversubscribed retail offer

Feb 10 2026

Read More
Deal Bird & Bird advises Kersia on the acquisition of part of the business of Polish company Radex

Feb 05 2026

Read More
News Bird & Bird boosts London Competition team with collective action expert Emma Radcliffe

Feb 03 2026

Read More
Deal Bird & Bird advised Search Fund Ulam Transmission on the acquisition of the S.A.M.U. group

Feb 03 2026

Read More
News Bird & Bird expands Energy & Utilities Sector Group with new partner in Munich

Feb 02 2026

Read More
News Bird & Bird boosts Warsaw Commercial team with double partner hire

Jan 30 2026

Read More
More News & Deals

Related capabilities

Corporate Venture Capital Technology & Communications Life Sciences and Healthcare